Literature DB >> 17377176

Gadolinium-based contrast media and the development of nephrogenic systemic fibrosis in patients with renal insufficiency.

Rush H Chewning1, Kieran J Murphy.   

Abstract

Gadolinium-based contrast media are important tools in diagnostic and interventional radiology that are particularly useful in patients with renal insufficiency. Recent reports in which exposure to gadolinium compounds has been linked to the development of nephrogenic systemic fibrosis in this patient population, however, are quite concerning. It is of great importance that radiologists be aware of this serious disease and exercise caution when considering the use of gadolinium-based contrast media in patients with moderate (glomerular filtration rate, <60 mL/min/1.73 m(2)) to severe (glomerular filtration rate, <15 mL/min/1.73 m(2)) renal disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17377176     DOI: 10.1016/j.jvir.2007.01.025

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  6 in total

1.  Non-enhanced, ECG-gated MR angiography of the pedal vasculature: comparison with contrast-enhanced MR angiography and digital subtraction angiography in peripheral arterial occlusive disease.

Authors:  Tilman Schubert; Martin Takes; Markus Aschwanden; Markus Klarhoefer; Tanja Haas; Augustinus L Jacob; David Liu; Andreas Gutzeit; Sebastian Kos
Journal:  Eur Radiol       Date:  2015-10-29       Impact factor: 5.315

2.  [Nephrogenic systemic fibrosis. Medical detective work in the 21st century].

Authors:  B Manger
Journal:  Z Rheumatol       Date:  2007-10       Impact factor: 1.372

3.  Intrathecal gadolinium: its time has come?

Authors:  W P Dillon
Journal:  AJNR Am J Neuroradiol       Date:  2008-01       Impact factor: 3.825

Review 4.  Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.

Authors:  Aaron Joseph L Villaraza; Ambika Bumb; Martin W Brechbiel
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

5.  Significant differences when using MDRD for GFR estimation compared to radionuclide measured clearance.

Authors:  A J Craig; A Britten; S D Heenan; A G Irwin
Journal:  Eur Radiol       Date:  2011-05-21       Impact factor: 5.315

6.  [Nephrogenic systemic fibrosis].

Authors:  W Samtleben
Journal:  Radiologe       Date:  2007-09       Impact factor: 0.635

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.